Finally, the current study highlighted the CAD protein and its link to disturbances in glutamate/GABA neurotransmitters; as well as 8 AD-related proteins detected by two ‘omics’ approaches as promising for anti-AD drug development. This evidence concerns the gene CAD and Alzheimer disease.